Independent Director and Chairman resigns for health reasons; Ashwani Bhatia appointed

Management Changes View source PDF Explain this filing

NIVABUPA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.1%Reaction day

₹84.00

prior close

₹84.26

announcement price

In-mkt

timing

Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)+0.0%-0.2% vs market

General Insurance peers, median of 5sector-1.5%+1.4% vs sector

On the reaction day the stock moved 0.2 pts less than Nifty Smallcap 250 and 1.4 pts more than its General Insurance peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.2

10m

-0.2

15m

-0.2

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.1+0.0-0.2-1.5+1.4

Next day

-2.4+0.6-3.0-0.4-2.0

-1.6+0.6-2.2+0.6-2.1

-3.0-1.2-1.8-0.4-2.6

-0.2+0.2-0.4+0.9-1.2

+0.0-1.0+1.0-0.6+0.6

+0.0+0.8-0.8-2.5+2.5

15d

+2.6+4.9-2.4+4.2-1.6

+3.0+6.2-3.2+1.7+1.3

+2.4+7.2-4.8-4.0+6.4

-3.6+8.8-12.4-6.0+2.4

UpDownMarket · Nifty Smallcap 250Sector · General Insurance peers, median of 5Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Mr. Milind Barve resigned as Independent Director and Chairman of Niva Bupa Health Insurance on June 2, 2026, citing persistent health issues and stating no other material reasons. Mr. Ashwani Bhatia, former SEBI Whole-Time Member and SBI Managing Director with over 40 years of experience in banking and capital markets, was appointed as his replacement as Independent Director and Chairman effective June 3, 2026.

Likely market impact

Smooth leadership transition with no governance red flags. New Chairman brings deep regulatory and banking expertise to the board.